Lactose (India) Faces Financial Challenges Amid Shift to Sideways Market Trend

Lactose (India), a microcap company in the Pharmaceuticals & Biotechnology sector, has recently undergone an evaluation adjustment. This revision in its score reflects a shift in technical trends, moving from a mildly bearish stance to a sideways position.
Key financial metrics indicate that Lactose (India) has faced challenges in its recent performance. The company reported a flat financial performance for the quarter ending Q1 FY25-26, with a notable decline in profit after tax (PAT) of 54.18% over the last six months. Additionally, the interest expense for the past nine months has shown growth of 23.68%.

The company's ability to service its debt is under scrutiny, highlighted by a high Debt to EBITDA ratio of 3.61 times. Furthermore, 26.07% of promoter shares are pledged, which can exert additional pressure on stock prices in a declining market.

Despite these challenges, Lactose (India) maintains an attractive valuation with a return on capital employed (ROCE) of 18.1 and a favorable enterprise value to capital employed ratio of 2.1. However, the stock has underperformed the broader market, with a return of -22.28% over the past year, compared to the BSE500's decline of -2.29%.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.